MUC1 Specific Immune Responses Enhanced by Coadministration of Liposomal DDA/MPLA and Lipoglycopeptide
Jingjing Du(Guilin Medical University), Jun Guo(Soochow University), Shihao Zhou(Central China Normal University), Wenbo Xu(Shenyang Institute of Automation), Ruyan Zhang(Gansu Agricultural University), Zi-Ru Cheng(Hubei Polytechnic University), Longsheng Wang(Hubei University of Technology)
Cited by 19
Related Papers
A Novel Coronavirus from Patients with Pneumonia in China, 2019
|New England Journal of Medicine|2020|30.5k
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
|The Lancet|2020|12.6k
The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice
|Nature|2020|1.2k